Erectile dysfunction in successfully treated lymphoma patients

Supportive Care in Cancer

Volumn 16, Issue 3, 2008, Pages 291-297

  Aksoy, Sercan ^a   Harputluoglu, Hakan ^a   Kilickap, Saadettin ^a   Dincer, Murat ^a   Dizdar, Omer ^a   Akdogan, Bulent ^a   Ozen, Haluk ^a   Erman, Mustafa ^a   Celik, Ismail ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Erectile dysfunction; Gonadotropins; Lymphoma; Radiotherapy

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FOLLITROPIN; LUTEINIZING HORMONE; PREDNISONE; TESTOSTERONE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HODGKIN DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PATIENT ASSESSMENT; PRIORITY JOURNAL; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; ERECTILE DYSFUNCTION; GONADOTROPINS; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 41149112348     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0307-y     Document Type: Article

References (23)

1. Althof SE (2002) Quality of life and erectile dysfunction. Urology 59:803-810
2. Giwercman A, Petersen PM (2000) Cancer and male infertility. Baillieres Best Pract Res Clin Endocrinol Metab 14:453-471
3. Bloom JR, Fobair P, Gritz E, Wellisch D, Spiegel D, Varghese A, Hoppe R (1993) Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 11:979-988
4. Brotons FB, Campos JC, Gonzalez-Correales R, Martin-Morales A, Moncada I, Pomerol JM (2004) Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction. Int J Impot Res 16(Suppl 2):S26-S39
5. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822-830
6. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S (2005) Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 47:80-85, discussion 85-86
7. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54-61
8. Das PK, Das BK, Sahu DC, Mohanty GN, Rath RN (1994) Male gonadal function in Hodgkin's disease before and after treatment. J Assoc Phys India 42:604-605
9. Schrader M, Muller M, Sofikitis N, Goessl C, Straub B, Miller K (2002) Testicular sperm extraction prior to treatment in azoospermic patients with Hodgkin's disease. Ann Oncol 13:333
10. Viviani S, Ragni G, Santoro A, Perotti L, Caccamo E, Negretti E, Valagussa P, Bonadonna G (1991) Testicular dysfunction in Hodgkin's disease before and after treatment. Eur J Cancer 27:1389-1392
11. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, Grotenhermen FJ, Tesch H, Bredenfeld H, Koch P, Nisters-Backes H, Wolf J, Engert A, Diehl V (2001) Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 12:1307-1311
12. Chapman RM, Sutcliffe SB, Malpas JS (1981) Male gonadal dysfunction in Hodgkin's disease. A prospective study. JAMA 245:1323-1328
13. Türk Androloji Derneǧi IIEF Validasyon Grubu (2002) Erektil İşlevi Uluslararasi Deǧerlendirme formu (IIEF) Türkçe Versiyonu,. 4. Ulusal Cinsel İşlev Bozukluklari Kongresi Özet Kitabi, İstanbul, vol 43
14. Hartmann JT, Albrecht C, Schmoll HJ, Kuczyk MA, Kollmannsberger C, Bokemeyer C (1999) Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer 80:801-807
15. Relander T, Cavallin-Stahl E, Garwicz S, Olsson AM, Willen M (2000) Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 35:52-63
16. Fossa SD, Aabyholm T, Vespestad S, Norman N, Ous S (1993) Semen quality after treatment for testicular cancer. Eur Urol 23:172-176
17. Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D (1986) Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 4:805-814
18. Tross S (1984) Psychological sequelae of cured cancer: testicular cancer as a model. In Current concepts in psycho-oncology. Memorial Sloan-Kettering, New York, pp 17-25
19. Cella D (1983) Psychosocial adjustment over time to the successful treatment of early versus late stage Hodgkin's disease in young adult men. Doctoral thesis. Graduate School of Loyola University, Chicago, Chicago
20. Chatterjee R, Palla K, Kottaridis PD (2004) Cavernosal arterial insufficiency and metabolic syndrome probably represent a common pathology of endothelial dysfunction in recipients of high-dose therapy and stem-cell transplantation. J Clin Oncol 22:2253-2254
21. Ragni G, Bestetti O, Santoro A, Viviani S, Di Pietro R, De Lauretis L (1985) Evaluation of semen and pituitary gonadotropin function in men with untreated Hodgkin's disease. Fertil Steril 43:927-930
22. Puscheck E, Philip PA, Jeyendran RS (2004) Male fertility preservation and cancer treatment. Cancer Treat Rev 30:173-180
23. Hoekstra HY, GJ-P, Sonneveld DJ, va Imhoff G, van d Wiel H, va Driel M, Schrafford Koops H, Sleijfer DT (1998) Sexuality after combined modality treatment for testicular cancer or Hodgkin's Disease; Is there a difference between both cancer survivor groups. The American Society of Clinical Oncology Annual Meeting, Los Angeles, CA